Suppr超能文献

主动脉夹层手术治疗的知识空白。

Knowledge gaps in surgical management for aortic dissection.

机构信息

Department of Cardiothoracic and Vascular Surgery, McGovern Medical School at UTHealth, Houston, 6400 Fannin Street, Suite #2850, Houston, TX 77030.

McGovern Medical School at UTHealth, Houston, TX.

出版信息

Semin Vasc Surg. 2022 Mar;35(1):35-42. doi: 10.1053/j.semvascsurg.2022.02.009. Epub 2022 Feb 22.

Abstract

Aortic dissection (AD) is recognized as a potentially fatal condition and its standard treatment has been surgical intervention for acute type A AD (TAAD) and complicated acute type B AD (TBAD), and medical management for uncomplicated acute type B AD. Due to rapidly evolving device technologies and minimally invasive surgical techniques that have lowered perioperative risk, there are paradigm shifts for the indications and treatment options for both TAAD and TBAD. In this article, we will discuss the current indications and treatment options for TAAD and TBAD by chronicity of the disease, which comprises four categories: acute TAAD, chronic (repaired) TAAD, acute TBAD, and chronic TBAD. We will also discuss the knowledge gaps in the current surgical management strategies and literature evidence. Open surgical intervention remains the reference standard for acute TAAD and chronic TAAD with complications until an endoprosthesis that will suit the complex anatomy of aortic root, ascending aorta, and aortic arch is developed. Thoracic endovascular aortic repair is now the first line for complicated acute and chronic TBADs. However, we need a larger trials to support the safety and durability of the procedures in patients with uncomplicated TBAD. Without additional data, patients are left to choose between existing treatment options, such as open surgical repair and stent-grafting.

摘要

主动脉夹层(AD)被认为是一种潜在致命的疾病,其标准治疗方法一直是急性 A 型 AD(TAAD)和复杂急性 B 型 AD(TBAD)的手术干预,以及非复杂急性 B 型 AD 的药物治疗。由于设备技术的迅速发展和微创外科技术降低了围手术期风险,TAAD 和 TBAD 的适应证和治疗选择都发生了范式转变。在本文中,我们将根据疾病的慢性程度讨论 TAAD 和 TBAD 的当前适应证和治疗选择,包括以下四类:急性 TAAD、慢性(修复)TAAD、急性 TBAD 和慢性 TBAD。我们还将讨论当前外科治疗策略和文献证据中的知识空白。开放手术干预仍然是急性 TAAD 和有并发症的慢性 TAAD 的参考标准,直到开发出适合主动脉根部、升主动脉和主动脉弓复杂解剖结构的内假体。胸主动脉腔内修复术现在是复杂急性和慢性 TBAD 的首选治疗方法。然而,我们需要更大的试验来支持这些手术在无并发症 TBAD 患者中的安全性和耐久性。在没有更多数据的情况下,患者只能在现有的治疗选择之间进行选择,例如开放手术修复和支架移植。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验